Company: ABBV
Filing Date: 2025-02-14
Form Type: 10-K
Source: 0001551152-25-000020
Chunk: 63

Company: AbbVie Inc.
Filing Date: 2025-02-14
Form: 10-K
Item: Item 3
Chunk 63
---
9 %50.3 %51.4 %50.6 %RinvoqUnited States$4,259 $2,824 $1,794 50.8 %57.4 %50.8 %57.4 %International1,712 1,145 728 49.6 %57.3 %57.0 %60.7 %Total$5,971 $3,969 $2,522 50.4 %57.4 %52.5 %58.4 %OncologyImbruvicaUnited States$2,448 $2,665 $3,426 (8.1)%(22.2)%(8.1)%(22.2)%Collaboration revenues899 931 1,142 (3.5)%(18.5)%(3.5)%(18.5)%Total$3,347 $3,596 $4,568 (6.9)%(21.3)%(6.9)%(21.3)%VenclextaUnited States$1,234 $1,087 $1,009 13.5 %7.8 %13.5 %7.8 %International1,349 1,201 1,000 12.3 %20.1 %18.0 %22.3 %Total$2,583 $2,288 $2,009 12.9 %13.9 %15.9 %15.0 %Elahere(a)United States$477 $— $— n/mn/mn/mn/mInternational2 — — n/mn/mn/mn/mTotal$479 $— $— n/mn/mn/mn/mEpkinlyCollaboration revenues$118 $28 $— >100.0 %n/m>100.0 %n/mInternational28 3 — >100.0 %n/m>100.0 %n/mTotal$146 $31 $— >100.0 %n/m>100.0 %n/mAestheticsBotox CosmeticUnited States$1,682 $1,670 $1,654 0.7 %1.